Cargando…
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study
BACKGROUND: Intravascular large B‐cell lymphoma (lVLBCL) is a very rare type of large B‐cell lymphoma. METHODS: We conducted a retrospective study on IVLBCL patients treated from 2000 to 2016 in LYSA cooperative group centers. RESULTS: Sixty‐five patients were identified in 23 centers. Median age at...
Autores principales: | Bonnet, Antoine, Bossard, Céline, Gabellier, Ludovic, Rohmer, Julien, Laghmari, Othman, Parrens, Marie, Sarkozy, Clémentine, Dulery, Rémy, Roland, Virginie, Llamas‐Gutierrez, Francisco, Oberic, Lucie, Fornecker, Luc‐Matthieu, Bounaix, Laura, Villemagne, Bruno, Szablewski, Vanessa, Choquet, Sylvain, Bouabdallah, Krimo, Traverse‐Glehen, Alexandra, Mohty, Mohamad, Sanhes, Laurence, Houot, Roch, Gastinne, Thomas, Leux, Christophe, Le Gouill, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554445/ https://www.ncbi.nlm.nih.gov/pubmed/35538643 http://dx.doi.org/10.1002/cam4.4742 |
Ejemplares similares
-
P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
por: Sarkozy, Clementine, et al.
Publicado: (2023) -
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
por: Paunescu, Alexandra-Cristina, et al.
Publicado: (2021) -
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
por: Paunescu, Alexandra‑Cristina, et al.
Publicado: (2021) -
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
por: Sibon, David, et al.
Publicado: (2022) -
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
por: Bonnet, Christophe, et al.
Publicado: (2022)